Predicting response to immune checkpoint blockade in recurrent/metastatic head and neck squamous cell carcinoma using personalized circulating tumor DNA

被引：0
|
作者：
Torres, Daniel A. Ruiz
Merkin, Ross D.
Mendel, Julia
Fisch, Adam S.
Roberts, Thomas J.
Patel, Manisha Jayandra
Park, Jong Chul
Chevalier, Amber
Murray, Clodagh
Gates, Lisa
Efthymiou, Vasileios
Pipinikas, Christodoulos
Wirth, Lori J.
Faden, Daniel
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA
[2] Harvard Med Sch, Dept Otolaryngol Head & Neck Surg, Boston, MA USA
[3] Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA
[4] NeoGenom Labs Inc, Cambridge, England
[5] NeoGenomics, Cambridge, England
[6] Massachusetts Gen Hosp, Ctr Head & Neck Cancers, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6051
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck
    Kacew, Alec J.
    Harris, Ethan J.
    Lorch, Jochen H.
    Schoenfeld, Jonathan D.
    Margalit, Danielle N.
    Kass, Jason, I
    Tishler, Roy B.
    Haddad, Robert, I
    Hanna, Glenn J.
    ORAL ONCOLOGY, 2020, 105
  • [2] Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
    Brandt, Anna
    Thiele, Benjamin
    Schultheiss, Christoph
    Daetwyler, Eveline
    Binder, Mascha
    CANCERS, 2023, 15 (07)
  • [3] Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
    Valero, Cristina
    Golkaram, Mahdi
    Vos, Joris L.
    Xu, Bin
    Fitzgerald, Conall
    Lee, Mark
    Kaplan, Shannon
    Han, Catherine Y.
    Pei, Xin
    Sarkar, Reith
    Boe, Lillian A.
    Pandey, Abhinav
    Koh, Elizabeth S.
    Zuur, Charlotte L.
    Solit, David B.
    Pawlowski, Traci
    Liu, Li
    Ho, Alan L.
    Chowell, Diego
    Riaz, Nadeem
    Chan, Timothy A.
    Morris, Luc G. T.
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (19):
  • [4] Dual Immune Checkpoint Blockade and Hypofractionated Radiation in Recurrent/Metastatic Squamous Cell Carcinomas of the Head and Neck Previously Treated with Immune Checkpoint Inhibitors
    Rodriguez, C. P.
    Fromm, J.
    Liao, J. J.
    Laramore, G. E.
    Lo, S. S.
    Goff, P. H.
    Santana-Davila, R.
    Martins, R. G.
    Futran, N.
    Houlton, J.
    Barber, B.
    Parvathaneni, U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E282 - E283
  • [5] Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Saleh, Khalil
    Daste, Amaury
    Martin, Nicolas
    Pons-Tostivint, Elvire
    Auperin, Anne
    Herrera-Gomez, Ruth Gabriela
    Baste-Rotllan, Neus
    Bidault, Francois
    Guigay, Joel
    Le Tourneau, Christophe
    Saada-Bouzid, Esma
    Even, Caroline
    EUROPEAN JOURNAL OF CANCER, 2019, 121 : 123 - 129
  • [6] Personalized circulating tumor DNA (ctDNA) analysis in patients with recurrent/metastatic head and neck squamous cell cancer (R/M HNSCC).
    Taylor, Kirsty
    Zou, Jinfeng
    Magalhaes Filho, Marcos Aurelio Fonseca
    Howarth, Karen
    Marsico, Giovanni
    Terrell, Samantha
    Jones, Gregory
    Knape, Charlene
    Forshew, Tim
    Oliva, Marc
    Spreafico, Anna
    Hansen, Aaron Richard
    McDade, Simon
    Coyle, Victoria M.
    Lawler, Mark
    Elimova, Elena
    Bratman, Scott Victor
    Siu, Lillian L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma
    Manukian, Gregor
    Bar-Ad, Voichita
    Lu, Bo
    Argiris, Athanassios
    Johnson, Jennifer M.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [8] Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma
    Li, Qun
    Shen, Zhisen
    Shen, Yi
    Deng, Hongxia
    Shen, Yiming
    Wang, Jianing
    Zhan, Guowen
    Zhou, Chongchang
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (06)
  • [9] Statin Drugs Are Associated With Response to Immune Checkpoint Blockade in Recurrent/Metastatic Head and Neck Cancer
    Kristoff, Tyler J.
    Evans, Sean
    Nayi, Pranay
    Abousaud, Marin
    Goyal, Subir
    Liu, Yuan
    Shin, Dong
    Steuer, Conor E.
    Saba, Nabil F.
    Schmitt, Nicole C.
    CANCER MEDICINE, 2025, 14 (05):
  • [10] Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma
    Pestana, Roberto Carmagnani
    Becnel, Melody
    Rubin, Maria Laura
    Torman, Danice K.
    Crespo, James
    Phan, Jack
    Hanna, Ehab
    Bell, Diana
    Glisson, Bonnie S.
    Johnson, Jason M.
    Lee, J. Jack
    Ferrarotto, Renata
    ORAL ONCOLOGY, 2020, 101
12345